Pfenex Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Pfenex Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					                 Pfenex Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
       Reference Code: GDPH207021D                                                                                                             Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Pfenex Inc. (Pfenex) is a biotechnology company. It carries out the production of
                                                                                                              Pfenex Inc., Pharmaceuticals & Healthcare, Key
      research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals.
                                                                                                              Facts
      The company's reagent, pre-clinical, and cGMP-grade proteins include hormones,
      chemokines, interferons, interleukins, growth factors, and cytokines; antibodies;                        Web Address                           www.pfenex.com
      enzymes; bacterial and viral antigens. It is involved in strain engineering and protein
                                                                                                               Revenue (US$ million)                                NA
      production for the development of biopharmaceutical therapeutics and vaccines for
      infectious diseases and oncology. Pfenex is headquartered in California, the US.                         Number of Employees                                  NA
      The company is dedicated to the rapid and reliable production of high quality                            GlobalData
      recombinant proteins.

      Financial Deals Landscape
        Pfenex Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007                    Pfenex Inc., Pharmaceuticals & Healthcare, Deals By Year,
        to YTD 2013                                                                       2007 to YTD 2013


                                                                                                                                  1        1
                                                                                                          1




                                                                                           No. of Deals

                                                                                                                 0         0                         0    0          0
                                                                                                          0
                                                                                                               2007       2008   2009     2010   2011    2012       YTD
                                                                                                                                                                    2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Pfenex Inc., Pharmaceuticals & Healthcare, Deals By                              Pfenex Inc., Pharmaceuticals & Healthcare, Deals By
         Region, 2007 to YTD 2013                                                         Therapy Area, 2007 to YTD 2013

                         10     9
          No. of Deals




                                                                                                                      2
                         8
                                                                                                          2
                                                                                           No. of Deals




                         6
                         4               2         2
                                                            1        1                                                                1
                         2                                                                                1
                         0
                              North     Asia-    Europe   Middle   South
                              Americ   Pacific             East     and                                                                          0              0
                                a                          and     Central                                0
                                                          Africa   Americ                                        Infectiou Oncology Cardiova             Central
                                                                     a                                           s Disease           scular              Nervous
                                                                                                                                                         System


         Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    Note: Deals include all announced pharmaceuticals & healthcare deals
                                                                                          from 2006 onwards, GlobalData




Pfenex Inc. - Pharmaceuticals & Healthcare - Deals and Alliances                                                                                 Reference Code: GDPH207021D
Profile
Source : www.globalcompanyintelligence.com                                                                                                                                  Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Pfenex Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013................................................................................ 3
       Pfenex Inc., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ................................................................................ 5
       Pfenex Inc., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ............................................................................ 6
       Pfenex Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ................................................................. 7
       Pfenex Inc., Pharmaceuticals & Healthcare, Partnerships, Deals By Therapy Area Vs Deal Value Vs Upfront Payment, 2007 to
       YTD 2013 ........................................................................................................................................................................................... 8
       Pfenex Inc., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Therapy Area Vs Deal Value Vs Upfront Payment, 2007 to
       YTD 2013 ........................................................................................................................................................................................... 9
       Pfenex Inc., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ........................................................................... 10
       Pfenex Inc., Pharmaceuticals & Healthcare, Deal Details ................................................................................................................ 11
          Venture Financing......................................................................................................................................................................... 11
             Pfenex Raises $24 Million In Venture Financing ....................................................................................................................... 11
          Partnerships.................................................................................................................................................................................. 12
             Pfenex Enters Into Co-Development Agreement With DNA2.0 ................................................................................................. 12
             Pfenex Enters Into Co-Development Agreement With ProZyme ............................................................................................... 13
             Pfenex Enters Into Collaboration With MedImmune .................................................................................................................. 14
             Pfenex Enters Into Collaboration With Boehringer Ingelheim.................................................................................................... 15
             Pfenex Enters Into Distribution Agreement With Cedarlane ...................................................................................................... 16
             Boston BioCom Enters Into Research Agreement With Pfenex ................................................................................................ 17
             Ranbaxy Labs Enters Into Co-Development Agreement With Pfenex ...................................................................................... 18
          Licensing Agreements .................................................................................................................................................................. 19
             Pfenex Enters Into Licensing Agreement With Merck ............................................................................................................... 19
       Pfenex Inc. - Key Competitors .......................................................................................................................................................... 20
       Key Employees ................................................................................................................................................................................ 21
       Locations And Subsidiaries .............................................................................................................................................................. 22
          Head Office ................................................................................................................................................................................... 22
       Appendix .......................................................................................................................................................................................... 23
          Methodology ................................................................................................................................................................................. 23
          About GlobalData ......................................................................................................................................................................... 23
          Contact Us .................................................................................................................................................................................... 23
          Disclaimer ..................................................................................................................................................................................... 23




Pfenex Inc. - Pharmaceuticals & Healthcare - Deals and Alliances                                                                                                 Reference Code: GDPH207021D
Profile
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       List of Tables
       Pfenex Inc., Pharmaceuticals & Healthcare, Key Facts ..........................
				
DOCUMENT INFO
Description: Pfenex Inc. (Pfenex) is a biotechnology company. It carries out the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. The company's reagent, pre-clinical, and cGMP-grade proteins include hormones, chemokines, interferons, interleukins, growth factors, and cytokines; antibodies; enzymes; bacterial and viral antigens. It is involved in strain engineering and protein production for the development of biopharmaceutical therapeutics and vaccines for infectious diseases and oncology. Pfenex is headquartered in California, the US.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.